Samsung Biologics Accuses Lotte of Stealing CDMO Trade Secrets
In a significant development in South Korea’s biopharmaceutical sector, contract development and manufacturing organization (CDMO) Samsung Biologics, one of the largest biopharmaceutical manufacturers in the world, has accused burgeoning competitor Lotte Biologics of trade secret theft. Samsung Biologics initiated the latest round of legal proceedings against Lotte in June, claiming illicit acquisition and utilization of…